104 related articles for article (PubMed ID: 12555214)
1. Thromboembolism preceding cancer: a correlation study.
Saba HI; Khalil FK; Morelli GA; Foulis PR
Am J Hematol; 2003 Feb; 72(2):109-14. PubMed ID: 12555214
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of cancer after primary deep venous thrombosis or pulmonary embolism].
Sørensen HT; Mellemkjaer L; Steffensen FH; Olsen JH; Nielsen GL
Lakartidningen; 2000 Apr; 97(16):1961-4. PubMed ID: 10826355
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival.
Jacobson G; Lammli J; Zamba G; Hua L; Goodheart MJ
Gynecol Oncol; 2009 May; 113(2):240-4. PubMed ID: 19251310
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
5. Incidence and diagnostic significance of paraneoplastic thromboembolism disorders. A survey from a community hospital.
Naschitz JE; Yeshurun D; Abrahamson J
Int Angiol; 1989; 8(1):28-31. PubMed ID: 2768955
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.
Jacobson GM; Kamath RS; Smith BJ; Goodheart MJ
Gynecol Oncol; 2005 Feb; 96(2):470-4. PubMed ID: 15661237
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
8. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
9. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study.
Gatt ME; Paltiel O; Bursztyn M
Thromb Haemost; 2004 Mar; 91(3):538-43. PubMed ID: 14983230
[TBL] [Abstract][Full Text] [Related]
10. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.
Kashuk JL; Moore EE; Sabel A; Barnett C; Haenel J; Le T; Pezold M; Lawrence J; Biffl WL; Cothren CC; Johnson JL
Surgery; 2009 Oct; 146(4):764-72; discussion 772-4. PubMed ID: 19789037
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
14. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
15. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
16. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
[TBL] [Abstract][Full Text] [Related]
17. A new scoring system to determine thromboembolic risk after heart valve replacement.
Butchart EG; Ionescu A; Payne N; Giddings J; Grunkemeier GL; Fraser AG
Circulation; 2003 Sep; 108 Suppl 1():II68-74. PubMed ID: 12970211
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with venous thromboembolic events in patients with malignancy.
Lin J; Wakefield TW; Henke PK
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):265-70. PubMed ID: 16651868
[TBL] [Abstract][Full Text] [Related]
19. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
[TBL] [Abstract][Full Text] [Related]
20. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.
Cushman M; Tsai AW; White RH; Heckbert SR; Rosamond WD; Enright P; Folsom AR
Am J Med; 2004 Jul; 117(1):19-25. PubMed ID: 15210384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
